前列腺磁共振波谱成像的进展
Advances in MR spectroscopy of the prostate.
作者信息
Kurhanewicz John, Vigneron Daniel B
机构信息
University of California, San Francisco, San Francisco, CA 94158, USA.
出版信息
Magn Reson Imaging Clin N Am. 2008 Nov;16(4):697-710, ix-x. doi: 10.1016/j.mric.2008.07.005.
Abstract
Commercial MR imaging/magnetic resonance spectroscopic imaging (MRSI) packages for staging prostate cancer on 1.5-T MR scanners are now available. The technology is becoming mature enough to begin assessing its clinical utility in selecting, planning, and following prostate cancer therapy. Before therapy, 1.5-T MR imaging/MRSI has the potential to improve the local evaluation of prostate cancer presence and volume and has a significant incremental benefit in the prediction of pathologic stage when added to clinical nomograms. After therapy, two metabolic biomarkers of effective and ineffective therapy have been identified and are being validated with 10-year outcomes. Accuracy can be improved by performing MR imaging/MRSI at higher magnetic field strengths, using more sensitive hyperpolarized (13)C MRSI techniques and through the addition of other functional MR techniques.
摘要
现在已有用于在1.5-T磁共振成像仪上对前列腺癌进行分期的商用磁共振成像/磁共振波谱成像（MRSI）软件包。该技术已足够成熟，可开始评估其在前列腺癌治疗的选择、规划和随访中的临床效用。在治疗前，1.5-T磁共振成像/MRSI有潜力改善对前列腺癌存在情况和体积的局部评估，并且在添加到临床列线图时，对病理分期的预测有显著的增量益处。治疗后，已确定了有效和无效治疗的两种代谢生物标志物，并正在通过10年的结果进行验证。通过在更高磁场强度下进行磁共振成像/MRSI、使用更灵敏的超极化（13）C MRSI技术以及添加其他功能性磁共振技术，可以提高准确性。
相似文献
1
Advances in MR spectroscopy of the prostate.前列腺磁共振波谱成像的进展
Magn Reson Imaging Clin N Am. 2008 Nov;16(4):697-710, ix-x. doi: 10.1016/j.mric.2008.07.005.
2
In vivo MR spectroscopic imaging of the prostate, from application to interpretation.前列腺的活体磁共振波谱成像：从应用到解读
Anal Biochem. 2017 Jul 15;529:158-170. doi: 10.1016/j.ab.2017.02.001. Epub 2017 Feb 3.
3
Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer.术前磁共振成像和波谱分析联合列线图预测前列腺癌的非显著性。
BJU Int. 2012 May;109(9):1315-22. doi: 10.1111/j.1464-410X.2011.10612.x. Epub 2011 Sep 20.
4
[MR spectroscopic imaging for evaluation of prostate cancer].[磁共振波谱成像在前列腺癌评估中的应用]
J Radiol. 2006 Feb;87(2 Pt 2):222-7. doi: 10.1016/s0221-0363(06)73996-8.
5
Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.对原位人体前列腺进行具有高空间分辨率（0.24 - 0.7立方厘米）的三维氢-1磁共振波谱成像。
Radiology. 1996 Mar;198(3):795-805. doi: 10.1148/radiology.198.3.8628874.
6
MR spectroscopic imaging: principles and recent advances.磁共振波谱成像：原理与最新进展。
J Magn Reson Imaging. 2013 Jun;37(6):1301-25. doi: 10.1002/jmri.23945. Epub 2012 Nov 27.
7
MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer.磁共振成像和磁共振波谱成像在前列腺癌治疗前评估中的应用
Br J Radiol. 2005;78 Spec No 2:S103-11. doi: 10.1259/bjr/11253478.
8
Magnetic resonance imaging and spectroscopic imaging of prostate cancer.前列腺癌的磁共振成像和磁共振波谱成像
J Urol. 2003 Dec;170(6 Pt 2):S69-75; discussion S75-6. doi: 10.1097/01.ju.0000094958.23276.c4.
9
Temporal B0 field variation effects on MRSI of the human prostate at 7 T and feasibility of correction using an internal field probe.7T时颞部B0场变化对人体前列腺磁共振波谱成像的影响及使用内部场探头进行校正的可行性。
NMR Biomed. 2014 Nov;27(11):1353-60. doi: 10.1002/nbm.3197. Epub 2014 Sep 12.
10
Spectroscopy in prostate cancer: hope or hype?前列腺癌中的光谱学：希望还是炒作？
Oncology (Williston Park). 2001 Nov;15(11):1399-410; discussion 1415-6, 1418.
引用本文的文献
1
The Use of Magnetic Resonance Imaging in Radiation Therapy Treatment Simulation and Planning.磁共振成像在放射治疗模拟和计划中的应用。
J Magn Reson Imaging. 2024 Nov;60(5):1786-1805. doi: 10.1002/jmri.29246. Epub 2024 Jan 24.
2
Comprehensive Literature Review of Hyperpolarized Carbon-13 MRI: The Road to Clinical Application.超极化碳-13磁共振成像的综合文献综述：通往临床应用之路
Metabolites. 2021 Apr 3;11(4):219. doi: 10.3390/metabo11040219.
3
Basic concepts and applications of functional magnetic resonance imaging for radiotherapy of prostate cancer.功能磁共振成像在前列腺癌放射治疗中的基本概念与应用
Phys Imaging Radiat Oncol. 2019 Feb 25;9:50-57. doi: 10.1016/j.phro.2019.02.001. eCollection 2019 Jan.
4
Omega-3 Fatty Acids Survey in Men under Active Surveillance for Prostate Cancer: from Intake to Prostate Tissue Level.《接受主动监测的前列腺癌男性患者体内 ω-3 脂肪酸的研究：从摄入量到前列腺组织水平》
Nutrients. 2019 Jul 16;11(7):1616. doi: 10.3390/nu11071616.
5
How rapid advances in imaging are defining the future of precision radiation oncology.影像学的快速发展如何定义精准放射肿瘤学的未来。
Br J Cancer. 2019 Apr;120(8):779-790. doi: 10.1038/s41416-019-0412-y. Epub 2019 Mar 26.
6
Testosterone, prolactin, and oncogenic regulation of the prostate gland. A new concept: Testosterone-independent malignancy is the development of prolactin-dependent malignancy!睾酮、催乳素与前列腺癌的致癌调控。一个新观点：非睾酮依赖性恶性肿瘤是催乳素依赖性恶性肿瘤的发展！
Oncol Rev. 2018 Jul 4;12(2):356. doi: 10.4081/oncol.2018.356.
7
Hyperpolarized carbon-13 magnetic resonance spectroscopic imaging: a clinical tool for studying tumour metabolism.超极化碳-13磁共振波谱成像：一种用于研究肿瘤代谢的临床工具。
Br J Radiol. 2018 May;91(1085):20170688. doi: 10.1259/bjr.20170688. Epub 2018 Jan 19.
8
Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic Opportunities.前列腺癌的代谢脆弱性：诊断和治疗机会。
Cold Spring Harb Perspect Med. 2018 Oct 1;8(10):a030569. doi: 10.1101/cshperspect.a030569.
9
Imaging Cancer Metabolism.癌症代谢成像
Biomol Ther (Seoul). 2018 Jan 1;26(1):81-92. doi: 10.4062/biomolther.2017.220.
10
A Metabolic Therapy for Malignant Glioma Requires a Clinical Measure.代谢疗法治疗恶性脑胶质瘤需要临床指标。
Curr Oncol Rep. 2017 Nov 2;19(12):84. doi: 10.1007/s11912-017-0637-y.
本文引用的文献
1
Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study.前列腺癌：前列腺切除术前磁共振成像和磁共振波谱成像的六分区定位——ACRIN前瞻性多机构临床病理研究结果
Radiology. 2009 Apr;251(1):122-33. doi: 10.1148/radiol.2511080409.
2
Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer.磁共振成像和磁共振波谱成像在前列腺癌放疗前后的作用
J Endourol. 2008 Apr;22(4):789-94. doi: 10.1089/end.2007.9822.
3
Multiparametric magnetic resonance imaging in prostate cancer: present and future.前列腺癌的多参数磁共振成像：现状与未来
Curr Opin Urol. 2008 Jan;18(1):71-7. doi: 10.1097/MOU.0b013e3282f19d01.
4
Class solution in inverse planned HDR prostate brachytherapy for dose escalation of DIL defined by combined MRI/MRSI.基于联合MRI/MRSI定义的剂量递增指数（DIL）的逆向计划高剂量率前列腺近距离治疗中的剂量解决方案。
Radiother Oncol. 2008 Jul;88(1):148-55. doi: 10.1016/j.radonc.2007.11.024. Epub 2008 Feb 20.
5
Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T-initial experience.3T下TRAMP小鼠的超极化碳-13光谱成像——初步经验
Magn Reson Med. 2007 Dec;58(6):1099-106. doi: 10.1002/mrm.21256.
6
In vivo 13 carbon metabolic imaging at 3T with hyperpolarized 13C-1-pyruvate.使用超极化13C-1-丙酮酸在3T下进行体内13碳代谢成像。
Magn Reson Med. 2007 Jul;58(1):65-69. doi: 10.1002/mrm.21253.
7
Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C.用于超极化13C快速光谱成像的双自旋回波序列。
J Magn Reson. 2007 Aug;187(2):357-62. doi: 10.1016/j.jmr.2007.05.014. Epub 2007 Jun 2.
8
Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram.惰性前列腺癌的预测：预后列线图的验证与更新
J Urol. 2007 Jan;177(1):107-12; discussion 112. doi: 10.1016/j.juro.2006.08.068.
9
Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis.用于体内肿瘤诊断的超极化13C磁共振成像代谢成像
Cancer Res. 2006 Nov 15;66(22):10855-60. doi: 10.1158/0008-5472.CAN-06-2564.
10
Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram.前列腺癌精囊侵犯的预测：在卡坦列线图基础上增加直肠内磁共振成像的增量价值。
Radiology. 2007 Jan;242(1):182-8. doi: 10.1148/radiol.2421051254. Epub 2006 Nov 7.
Zotero 插件